Antitumor Properties of an IgG2-Enhanced Next-Generation MET Monoclonal Antibody That Degrades Wild-Type and Mutant MET Receptors.

Abstract:

:A sound rationale exists for antibody targeting of the MET receptor tyrosine kinase, but therapeutic agents that can broadly block HGF ligand binding and exon 14-mutated or amplified MET to induce receptor degradation have yet to be reported. Here we report the identification of several MET monoclonal antibodies (mAb) that block MET-dependent signaling and tumor growth. In particular, the MET mAb KTN0073 and KTN0074 bind the Sema/PSI domain, at overlapping but distinct epitopes, preventing HGF interaction with MET and triggering receptor ubiquitination and degradation. Notably, both mAbs also triggered degradation of oncogenic MET exon 14 mutants, which propagate more durable MET signals due to a defect in receptor degradation. Mechanistic investigations showed that both mAbs engaged a pathway distinct from HGF-induced receptor degradation and protease-mediated shedding, independently of signaling driven by the exon 14-encoded sequences in the intracellular juxtamembrane region of the MET receptor. Grafting the mAb variable regions onto the IgG2 constant region dramatically enhanced the tumor inhibitory activities of KTN0073 but not KTN0074, suggesting a specific influence of antibody isotype of the epitopes for these two MET mAbs. Overall, our results highlight KTN0073 as a novel IgG2-based MET mAb that acts through exon 14-independent mechanisms to degrade the MET receptor, potentially offering a therapeutic tool to treat a broader range of human tumors where MET is exon 14 mutated or amplified. Cancer Res; 76(19); 5788-97. ©2016 AACR.

journal_name

Cancer Res

journal_title

Cancer research

authors

Yang Y,Mandiyan S,Robinson BS,McMahon G

doi

10.1158/0008-5472.CAN-16-0026

subject

Has Abstract

pub_date

2016-10-01 00:00:00

pages

5788-5797

issue

19

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-16-0026

journal_volume

76

pub_type

杂志文章
  • Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.

    abstract::Oncogene activation and loss of tumor suppressor function changes the metabolic activity of cancer cells to drive unrestricted proliferation. Moreover, cancer cells adapt their metabolism to sustain growth and survival when access to oxygen and nutrients is restricted, such as in poorly vascularized tumor areas. We sh...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-0650

    authors: Kaymak I,Maier CR,Schmitz W,Campbell AD,Dankworth B,Ade CP,Walz S,Paauwe M,Kalogirou C,Marouf H,Rosenfeldt MT,Gay DM,McGregor GH,Sansom OJ,Schulze A

    更新日期:2020-01-15 00:00:00

  • Fluorodeoxyuridine modulates cellular expression of the DNA base excision repair enzyme uracil-DNA glycosylase.

    abstract::The thymidylate synthase inhibitor 5-fluorouracil (5-FU) continues to play a pivotal role in the treatment of cancer. A downstream event of thymidylate synthase inhibition involves the induction of a self-defeating base excision repair process. With the depletion of TTP pools, there is also an increase in dUMP. Metabo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0540

    authors: Fischer JA,Muller-Weeks S,Caradonna SJ

    更新日期:2006-09-01 00:00:00

  • Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers.

    abstract::Several lines of evidence suggest that apoptosis dysregulation plays an important role in cancer metastasis. In this study, to explore the possibility that the mutations of death receptors are involved in the metastasis mechanism, we analyzed the death domains of Fas and tumor necrosis factor-related apoptosis-inducin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shin MS,Kim HS,Lee SH,Park WS,Kim SY,Park JY,Lee JH,Lee SK,Lee SN,Jung SS,Han JY,Kim H,Lee JY,Yoo NJ

    更新日期:2001-07-01 00:00:00

  • In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.

    abstract::The effects of a combination of simvastatin, a cholesterol-lowering agent, and carmustine (BCNU; N,N'-bis(2-chloroethyl)-N-nitrosourea) on experimental C6 glioma were studied in vitro and in vivo. In vitro simvastatin and BCNU alone inhibited cell proliferation in a dose-dependent fashion. A subliminal concentration o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Soma MR,Baetta R,De Renzis MR,Mazzini G,Davegna C,Magrassi L,Butti G,Pezzotta S,Paoletti R,Fumagalli R

    更新日期:1995-02-01 00:00:00

  • An experimental approach to relate a tumor-associated enzyme marker to tumor cell numbers.

    abstract::Alkaline phosphatase was monitored in 17 mice with s.c.-implanted tumors to relate the total circulating alkaline phosphatase to the total number of tumor cells in each mouse. There was a semilogarithmic relationship between the alkaline phosphatase units and the number of tumor cells. A time-independent standard plot...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hiramoto RN,Ghanta VK,Soong SJ,Hurst DC

    更新日期:1977-02-01 00:00:00

  • Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy.

    abstract::We have applied Raman spectroscopy to analyze the chemical composition of microcalcifications occurring in benign and malignant lesions in the human breast. Microcalcifications were initially separated into two categories based on their Raman spectrum: type I, calcium oxalate dihydrate, and type II, calcium hydroxyapa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Haka AS,Shafer-Peltier KE,Fitzmaurice M,Crowe J,Dasari RR,Feld MS

    更新日期:2002-09-15 00:00:00

  • Activation of stat3 in human melanoma promotes brain metastasis.

    abstract::Brain metastasis is a major cause of morbidity and mortality in patients with melanoma. The molecular changes that lead to brain metastasis remain poorly understood. In this study, we developed a model to study human melanoma brain metastasis and found that Stat3 activity was increased in human brain metastatic melano...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2674

    authors: Xie TX,Huang FJ,Aldape KD,Kang SH,Liu M,Gershenwald JE,Xie K,Sawaya R,Huang S

    更新日期:2006-03-15 00:00:00

  • Relationship between urine and plasma estrogen ratios.

    abstract::Normal young and postmenopausal women were placed into groups according to the ratio of the estrogens in their urine. Women whose ratio was greater than 1.3 if young and greater than 3.2 if postmenopausal were compared to women whose ratio was less than 0.7 and less than 2.1 for young and postmenopausal, respectively....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Longcope C,Pratt JH

    更新日期:1978-11-01 00:00:00

  • Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.

    abstract::The antitumor activity of IFN-alpha is well established. However, the role of the plasmacytoid dendritic cell (PDC), the major producer of IFN-alpha upon viral infection, in tumor biology is unknown. We sought to study the presence and function of PDC in a human solid tumor. Here, we demonstrate that PDCs infiltrate t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hartmann E,Wollenberg B,Rothenfusser S,Wagner M,Wellisch D,Mack B,Giese T,Gires O,Endres S,Hartmann G

    更新日期:2003-10-01 00:00:00

  • Altered amino acid kinetics in rats with progressive tumor growth.

    abstract::The present study was designed to determine whether alterations in host metabolism associated with progressive tumor growth were a result of the anorexia frequently observed with cancer or could be attributed to other direct tumor effects. Rates of tyrosine flux, oxidation, and incorporation into protein, as well as f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kawamura I,Moldawer LL,Keenan RA,Batist G,Bothe A Jr,Bistrian BR,Blackburn GL

    更新日期:1982-03-01 00:00:00

  • Detection of precancerous cervical lesions is differential by human papillomavirus type.

    abstract::Epidemiologic studies have reported the underrepresentation of cervical precancerous lesions caused by human papillomavirus (HPV) types 18 and 45 (HPV18/45) compared with the proportion of cervical cancers attributed to these HPV types. We investigated the timing of diagnosis of histologic cervical intraepithelial neo...

    journal_title:Cancer research

    pub_type: 杂志文章,随机对照试验

    doi:10.1158/0008-5472.CAN-08-4192

    authors: Safaeian M,Schiffman M,Gage J,Solomon D,Wheeler CM,Castle PE

    更新日期:2009-04-15 00:00:00

  • STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.

    abstract::Tumors routinely attract and co-opt macrophages to promote their growth, angiogenesis, and metastasis. Macrophages are also the key effector cell for mAb therapies. Here we report that the tumor microenvironment creates an immunosuppressive signature on tumor-associated macrophages (TAM), which favors expression of in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-2784

    authors: Dahal LN,Dou L,Hussain K,Liu R,Earley A,Cox KL,Murinello S,Tracy I,Forconi F,Steele AJ,Duriez PJ,Gomez-Nicola D,Teeling JL,Glennie MJ,Cragg MS,Beers SA

    更新日期:2017-07-01 00:00:00

  • Sensitivity of subpopulations of mouse skin papillomas to malignant conversion by urethane or 4-nitroquinoline N-oxide.

    abstract::Papillomas induced in SENCAR mice by initiation with 7,12-dimethylbenz(a)anthracene and promotion by treatment for 10-12 weeks with 12-O-tetradecanoylphorbol-13-acetate (TPA) convert to malignancy at a low frequency. The rate of malignant conversion can be increased by either (a) promoting with TPA for a shorter durat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hennings H,Shores R,Balaschak M,Yuspa SH

    更新日期:1990-02-01 00:00:00

  • Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.

    abstract::Hybridoma-derived monoclonal anti-colorectal carcinoma antibodies suppressed the growth of colorectal carcinoma in nude mice as evidenced by a lower incidence of tumors, a longer latency period, and a smaller volume of tumors in antibody-treated than in control animals. The growth-inhibiting properties of monoclonal a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Herlyn DM,Steplewski Z,Herlyn MF,Koprowski H

    更新日期:1980-03-01 00:00:00

  • β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.

    abstract::Antiangiogenic therapies like bevacizumab offer promise for cancer treatment, but acquired resistance, which often includes an aggressive mesenchymal phenotype, can limit the use of these agents. Upregulation of β1 integrin (ITGB1) occurs in some bevacizumab-resistant glioblastomas (BRG) whereby, mediating tumor-micro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0011

    authors: Carbonell WS,DeLay M,Jahangiri A,Park CC,Aghi MK

    更新日期:2013-05-15 00:00:00

  • Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap.

    abstract::Cancer research has long been hampered by the limitations of the current model systems. Both cultured cells and mouse xenografts grow in an environment highly dissimilar to that of their originating tumor, frequently resulting in promising treatments that are ultimately clinically ineffective. The development of highl...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-16-1260

    authors: Morton JJ,Bird G,Refaeli Y,Jimeno A

    更新日期:2016-11-01 00:00:00

  • Tumor-caused changes in host protein synthesis under different dietary situations.

    abstract::The effect of the AC33 tumor on protein synthesis in Lewis-Wistar rats was investigated under four different dietary regimens. The four diets used were: (a) 1.25 g amino acids plus 12.5 g glucose per day, (b) 1.25 g amino acids, (c) 1.25 g glucose per day, and (d) 12.5 g glucose per day. The rats were maintained on th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Stein TP,Oram-Smith JC,Leskiw MJ,Wallace HW,Miller EE

    更新日期:1976-11-01 00:00:00

  • Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.

    abstract::CBLC (CBL proto-oncogene c) belongs to the CBL protein family, which has E3 ubiquitin ligase activity toward activated receptor tyrosine kinases. CBLC is frequently upregulated in non-small cell lung cancer (NSCLC), yet very little is known about the functions of CBLC in tumorigenesis. Here we show that CBLC is an epi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-3858

    authors: Hong SY,Kao YR,Lee TC,Wu CW

    更新日期:2018-09-01 00:00:00

  • Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole.

    abstract::Approximately 25% of breast cancers do not express the estrogen receptor-α (ERα) and consequently do not respond to endocrine therapy. In these tumors, ERα repression is often due to epigenetic modifications such as methylation and histone deacetylation. For this reason, we investigated the ability of the histone deac...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2458

    authors: Sabnis GJ,Goloubeva O,Chumsri S,Nguyen N,Sukumar S,Brodie AM

    更新日期:2011-03-01 00:00:00

  • Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.

    abstract::Mutations in the adenomatous polyposis coli (APC) gene and K-ras occur in the majority of human colorectal cancers. Loss of functional APC protein activates the Wnt signal transduction pathway, allowing the nuclear accumulation of beta-catenin, which then binds to T-cell factor-4 (Tcf-4), causing increased transcripti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Araki Y,Okamura S,Hussain SP,Nagashima M,He P,Shiseki M,Miura K,Harris CC

    更新日期:2003-02-01 00:00:00

  • Effects of iodine deficiency and high-fat diet on N-nitrosomethylurea-induced mammary cancers in rats.

    abstract::The effects of an altered content of dietary iodine and fat on the development of N-nitrosomethylurea-induced mammary tumors in rats were studied and correlated with thyroid and pituitary function studies. In three separate experiments, animals fed a semisynthetic diet containing 11.8% fat had an earlier time of tumor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cave WT Jr,Dunn JT,MacLeod RM

    更新日期:1979-03-01 00:00:00

  • Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.

    abstract::Galectin-3 (Gal-3), a pleiotropic carbohydrate-binding protein, is a selective binding partner of activated K-Ras-GTP. Because both proteins are antiapoptotic and associated with cancer progression, we questioned the possible functional role of Gal-3 in K-Ras activation. We found that overexpression of Gal-3 in human ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0775

    authors: Shalom-Feuerstein R,Cooks T,Raz A,Kloog Y

    更新日期:2005-08-15 00:00:00

  • Patient-derived tumor xenografts: transforming clinical samples into mouse models.

    abstract::Tumor graft models (also known as patient-derived xenografts or PDX) are based on the transfer of primary tumors directly from the patient into an immunodeficient mouse. Because PDX mice are derived from human tumors, they offer a tool for developing anticancer therapies and personalized medicine for patients with can...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-13-1069

    authors: Siolas D,Hannon GJ

    更新日期:2013-09-01 00:00:00

  • Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.

    abstract::E-cadherin loss is frequently associated with ovarian cancer metastasis. Given that adhesion to the abdominal peritoneum is the first step in ovarian cancer dissemination, we reasoned that down-regulation of E-cadherin would affect expression of cell matrix adhesion receptors. We show here that inhibition of E-cadheri...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5167

    authors: Sawada K,Mitra AK,Radjabi AR,Bhaskar V,Kistner EO,Tretiakova M,Jagadeeswaran S,Montag A,Becker A,Kenny HA,Peter ME,Ramakrishnan V,Yamada SD,Lengyel E

    更新日期:2008-04-01 00:00:00

  • Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II).

    abstract::cis- and trans-diamminedichloroplatinum(II) (PDD) produced a DNA cross-linking effect in mouse leukemia L1210 cells, which was demonstrable after subtoxic treatments with the DNA alkaline elution technique. Cross-linking effects developed following treatments with concentrations as low as 1 micron for cis-PDD and 5 mi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zwelling LA,Kohn KW,Ross WE,Ewig RA,Anderson T

    更新日期:1978-06-01 00:00:00

  • Human ovarian carcinoma cells maintained on extracellular matrix versus plastic.

    abstract::The ability of culture dishes coated with an extracellular matrix (ECM) to act as a suitable substrate for human ovarian carcinoma cells in vitro has been examined. The plating efficiency on ECM was 30 to 80% (dispersed tumor cells from solid tumor tissue and effusions) with active proliferation of tumor cells being o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Crickard K,Crickard U,Yoonessi M

    更新日期:1983-06-01 00:00:00

  • Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinoma.

    abstract::Because efficient i.v. administration of interleukin 2 (IL-2) in tumor patients leads to severe cardiopulmonary side effects, we developed a new form of IL-2 application that allows activation of all IL-2-responsive immune cells directly at the tumor site. In five patients with T4N0M0 transitional cell carcinoma of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Huland E,Huland H

    更新日期:1989-10-01 00:00:00

  • Therapeutic Potential of Bacteria against Solid Tumors.

    abstract::Intentional bacterial infections can produce efficacious antitumor responses in mice, rats, dogs, and humans. However, low overall success rates and intense side effects prevent such approaches from being employed clinically. In this work, we titered bacteria and/or the proinflammatory cytokine TNFα in a set of establ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-1621

    authors: Hatzikirou H,López Alfonso JC,Leschner S,Weiss S,Meyer-Hermann M

    更新日期:2017-04-01 00:00:00

  • Molecular interactions of the combined effects of bleomycin and x-rays on mammalian cell survival.

    abstract::The interactions between bleomycin and X-ray damage and repair have been examined in rat and human tumor cells. Bleomycin itself indices extensive DNA single-strand breaks but does not appear to inhibit the repair of X-ray-induced DNA single-strand breaks. Quantitative analysis of these interactions is complicated by ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Byfield JE,Lee YC,Tu L,Kulhanian F

    更新日期:1976-03-01 00:00:00

  • Dysfunction of Poly (ADP-Ribose) Glycohydrolase Induces a Synthetic Lethal Effect in Dual Specificity Phosphatase 22-Deficient Lung Cancer Cells.

    abstract::Poly (ADP-ribose) glycohydrolase (PARG) is the main enzyme responsible for catabolism of poly (ADP-ribose) (PAR), synthesized by PARP. PARG dysfunction sensitizes certain cancer cells to alkylating agents and cisplatin by perturbing the DNA damage response. The gene mutations that sensitize cancer cells to PARG dysfun...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1037

    authors: Sasaki Y,Fujimori H,Hozumi M,Onodera T,Nozaki T,Murakami Y,Ashizawa K,Inoue K,Koizumi F,Masutani M

    更新日期:2019-08-01 00:00:00